Business Context and Reporting Period
This Form 8-K filing by Anthem, Inc. (now Elevance Health, Inc.) was submitted on February 1, 2017. The report serves to disclose the company's financial results for the fourth quarter and the full year ended December 31, 2016, via a press release furnished as Exhibit 99.1.
Key Financial Metrics
The filing text itself does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the referenced press release (Exhibit 99.1) and are not explicitly detailed in the body of this 8-K document.
Material Changes
The filing does not list specific material changes or comparative financial data versus prior periods. It solely references the issuance of the press release containing the fourth quarter and full-year 2016 results.
Guidance, Outlook, and Risks
No guidance, outlook, management commentary, risks, contingencies, or unusual items are described in the text of this filing. The document includes a standard disclaimer stating that the information furnished in Item 2.02 and Exhibit 99.1 is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and is not incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated February 1, 2017) for specific revenue, earnings, and margin figures.
- Verify the company's name change status, as the filing lists "Anthem, Inc." while the metadata references "Elevance Health, Inc."
- Confirm that the financial results for Q4 and full-year 2016 align with analyst expectations.
- Check subsequent filings for any updates to the forward-looking statements originally contained in the press release.